Posts Tagged ‘Whitehead Institute’

Mass grabs three top places for scientists to work

Thursday, March 4th, 2010

By Julie Donnelly

Julie DonnellySome of the best places for scientists to work for no money are here in Massachusetts. The Scientist magazine has put out its yearly “Best Places to Work” list for post-docs, and three of the top ten are located in Massachusetts. For the uninitiated, post-docs are the low men and women on the scientific totem pole. They toil for long hours in the bowels of Harvard and MIT buildings with no one to talk to but transgenic mice. They get paid something like $40,000, even though they all have Ph.D.s already. They do it because it helps enhance their resumes or, in this economy, because it’s a good alternative to the frosty job search process.

Post-docs are the lifeblood of early stage research, and although most of that research ultimately fails, there would be far fewer drugs on the market today if the post-doc system did not exist. Treating them well would seem to be a societal good.

The most fulfilled post-docs in Massachusetts work at the Whitehead Institute at MIT, according to The Scientist. The survey ranked the institute the third best place to work, out of the top 40 listed in the survey. Workers there said they benefited from exemplary facilities, infrastructure and funding to support their research. However, they gave the Whitehead low marks for communication and being conducive to family and personal life.

The fourth favorite research institution in the national survey wasn’t at Harvard — it was at Swiss drug maker Novartis’ Institutes for Biomedical Research in Cambridge. There, workers extolled Novartis’ equitable workplace and the benefits. But there too, post-docs complained their personal lives had to suffer.

Coming in at number nine on the list was Woods Hole Oceanographic Institution. Here, the workers surveyed said their jobs allowed for family and personal life and offered great opportunities for career development. Woods-Hole post docs said the drawbacks were the facilities and infrastructure, as well as the benefits.

NewsFlash Roundup: Aura Biosciences, Biogen, CloudSwitch

Monday, June 29th, 2009

Shares drop, lawsuits grow and personnel move in today’s NewsFlash Roundup:

• Bhatia, Best, Kivel join Aura Biosciences advisory boards

Aura Biosciences, a Cambridge-based biotechnology company focused on new drug delivery methods, has added three Boston-area advisors to its leadership team.

Biogen shares drop on 10th Tysabri PML case

Shares of Biogen Idec Inc. sank Monday after the biotechnology giant confirmed that another patient taking the multiple sclerosis drug Tysabri has been diagnosed with a potentially fatal brain infection called progressive multifocal leukoencephalopathy, or PML.

New funding, CEO and HQ for CloudSwitch

Former SolidWorks Corp. CEO John McEleney will join the company along with the round of funding, which was led by new investors Commonwealth Capital Ventures, and increase the total amount invested in Cloudswitch to $15.4 million. (more…)

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.